Scibase AB
SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin c… Read more
Scibase AB (SCIB) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.516x
Based on the latest financial reports, Scibase AB (SCIB) has a cash flow conversion efficiency ratio of -0.516x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-17.29 Million) by net assets (Skr33.48 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Scibase AB - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Scibase AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Scibase AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Scibase AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alianza Minerals Ltd
OTCQB:TARSF
|
-0.022x |
|
General Environmental Management Inc
PINK:GEVI
|
-0.172x |
|
Solueta Co Ltd
KQ:154040
|
0.117x |
|
Infrared Cameras Holdings Inc
NASDAQ:MSAI
|
-0.218x |
|
Phol Dhanya Public Company Limited
BK:PHOL
|
0.109x |
|
Careplus Group Bhd
KLSE:0163
|
-0.058x |
|
Cielo Waste Solutions Corp
PINK:CWSFF
|
0.082x |
|
Organic Tea Cosmetics Holdings Company Limited
KQ:900300
|
0.098x |
Annual Cash Flow Conversion Efficiency for Scibase AB (2012–2024)
The table below shows the annual cash flow conversion efficiency of Scibase AB from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr36.65 Million | Skr-57.38 Million | -1.566x | -29.68% |
| 2023-12-31 | Skr43.06 Million | Skr-51.98 Million | -1.207x | +31.48% |
| 2022-12-31 | Skr25.24 Million | Skr-44.47 Million | -1.762x | -215.78% |
| 2021-12-31 | Skr70.80 Million | Skr-39.50 Million | -0.558x | +22.78% |
| 2020-12-31 | Skr46.86 Million | Skr-33.86 Million | -0.723x | +39.05% |
| 2019-12-31 | Skr32.01 Million | Skr-37.96 Million | -1.186x | -126.10% |
| 2018-12-31 | Skr71.48 Million | Skr-37.48 Million | -0.524x | -37.36% |
| 2017-12-31 | Skr115.72 Million | Skr-44.18 Million | -0.382x | -47.93% |
| 2016-12-31 | Skr185.41 Million | Skr-47.85 Million | -0.258x | -61.43% |
| 2015-12-31 | Skr291.42 Million | Skr-46.59 Million | -0.160x | +85.92% |
| 2014-12-31 | Skr32.65 Million | Skr-37.08 Million | -1.136x | -20.76% |
| 2013-12-31 | Skr36.18 Million | Skr-34.03 Million | -0.940x | -161.14% |
| 2012-12-31 | Skr-23.69 Million | Skr-36.44 Million | 1.538x | -- |